Traders Purchase High Volume of Tilray Call Options (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) was the recipient of unusually large options trading activity on Friday. Stock traders bought 72,984 call options on the stock. This is an increase of approximately 61% compared to the average volume of 45,257 call options.

Analyst Upgrades and Downgrades

Separately, Roth Mkm lowered their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a report on Friday, October 11th.

Insider Transactions at Tilray

In other news, CFO Carl A. Merton bought 26,000 shares of the stock in a transaction dated Friday, November 15th. The stock was purchased at an average cost of $1.36 per share, for a total transaction of $35,360.00. Following the transaction, the chief financial officer now owns 26,000 shares of the company’s stock, valued at $35,360. The trade was a ? increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.87% of the company’s stock.

Institutional Trading of Tilray

A number of large investors have recently made changes to their positions in the stock. TD Asset Management Inc lifted its holdings in shares of Tilray by 8.1% in the 2nd quarter. TD Asset Management Inc now owns 1,373,045 shares of the company’s stock worth $2,278,000 after buying an additional 103,207 shares during the period. Arizona State Retirement System grew its holdings in Tilray by 4.4% during the 2nd quarter. Arizona State Retirement System now owns 216,693 shares of the company’s stock worth $360,000 after acquiring an additional 9,171 shares in the last quarter. PFG Investments LLC increased its position in Tilray by 22.2% during the 2nd quarter. PFG Investments LLC now owns 157,846 shares of the company’s stock valued at $262,000 after purchasing an additional 28,647 shares during the period. Vanguard Capital Wealth Advisors bought a new stake in shares of Tilray in the 2nd quarter valued at about $34,000. Finally, J.W. Cole Advisors Inc. lifted its stake in shares of Tilray by 1,077.2% during the 2nd quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock worth $284,000 after purchasing an additional 156,524 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Price Performance

Tilray stock opened at $1.23 on Friday. Tilray has a 12-month low of $1.14 and a 12-month high of $2.97. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The firm has a 50-day moving average price of $1.37 and a 200-day moving average price of $1.62. The firm has a market capitalization of $1.11 billion, a PE ratio of -4.56 and a beta of 2.08.

Tilray (NASDAQ:TLRY) last announced its quarterly earnings data on Friday, January 10th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The firm had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts forecast that Tilray will post -0.14 EPS for the current year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.